Author: Kevin Grogan

A study has been published which shows that while some aspects of care have improved for chronic obstructive pulmonary disease over the last six years, standards differ greatly across England and Wales.

Advisors to the US Food and Drug Administration will meet at the end of April to review Amgen’s closely-watched oncolytic immunotherapy T-Vec for melanoma.

GSK has acquired GlycoVaxyn, the Swiss vaccine-maker it has held a minority stake in since 2012, paying $190 million in cash to take full ownership.

The NGO Doctors of the World (Médecins du Monde) is contesting Gilead Sciences’ intellectual property on Sovaldi as part of a campaign to cut prices on the blockbuster hepatitis C drug.

Pfenex and Hospira, which is in the process of being acquired by Pfizer, are teaming up to develop the former’s biosimilar of Roche and Novartis’ eye blockbuster Lucentis.